Sotrovimab retains activity against SARS-CoV-2 omicron variant BQ.1.1 in a non-human primate model.
Hérate C, Marlin R, Touret F, Dereuddre-Bosquet N, Donati F, Relouzat F, Junges L, Galhaut M, Dehan O, Sconosciuti Q, Nougairède A, de Lamballerie X, van der Werf S, Le Grand R.
Hérate C, et al. Among authors: nougairede a.
Heliyon. 2023 Jun;9(6):e16664. doi: 10.1016/j.heliyon.2023.e16664. Epub 2023 May 30.
Heliyon. 2023.
PMID: 37287613
Free PMC article.